Core Insights - Milestone Scientific Inc. reported a 25% increase in revenue for Q2 2025, reaching $2.3 million, primarily driven by strong international dental sales which more than doubled year-over-year [2][3] - The company has strengthened its leadership team, appointing Eric Hines as the new CEO and Jason Papes as Senior Vice President, Global Head of Sales and Marketing, to support its growth strategy [2] - The gross margin for Q2 2025 was maintained at 70%, reflecting the high-margin dental business and effective cost management [2] Financial Performance - For Q2 2025, revenues were approximately $2.3 million, up from $1.9 million in Q2 2024, marking an increase of about $470,000 [3] - International revenue for Q2 2025 was approximately $1.0 million, an increase of approximately $524,000 compared to the same period in 2024 [3] - The net loss for Q2 2025 was approximately $(1.5) million, or $(0.02) per share, compared to a net profit of $0.2 million, or $0.00 per share, in Q2 2024 [3] Business Strategy - The company aims to accelerate growth in both dental and medical segments by enhancing its direct sales model, e-commerce platform, and targeted marketing campaigns [2] - In the medical segment, Milestone Scientific is focusing on advancing the adoption of its CompuFlo® Epidural System, having secured Medicare Part B payment rate assignment and initial coverage from commercial insurers [2] - Future plans include broadening federal presence, expanding internationally with new distribution partners, and unlocking potential in both business segments [2] Leadership Changes - Eric Hines, the new CEO, is expected to guide the company through its next growth phase, leveraging his experience in operational excellence [2] - Jason Papes brings a proven track record in global sales strategies, enhancing the company's capabilities in sales and marketing [2] - Shanth Thiyagalingam has joined the Board of Directors, contributing over 20 years of medtech executive experience [2] Cash Position - As of June 30, 2025, the company reported cash and cash equivalents of approximately $1.3 million and working capital of approximately $3.9 million [6]

Core Viewpoint - Milestone Scientific Inc. will host a conference call to discuss its financial results for Q2 2025 and corporate developments [1] Group 1: Conference Call Details - The conference call is scheduled for 8:00 AM Eastern Time on August 15, 2025 [1] - U.S. callers can dial toll-free 888-506-0062, while international callers can use +1 973-528-0011 with access code 470429 [2] - An audio replay will be available until August 29, 2025, accessible via 877-481-4010 for U.S. callers and +1 919-882-2331 for international callers with access code 52876 [3] Group 2: Company Overview - Milestone Scientific Inc. is a technology-focused medical research and development company specializing in innovative injection technologies for medical, dental, and cosmetic applications [4] - The company’s computer-controlled systems aim to enhance injection precision, efficiency, and patient comfort and safety [4] - The proprietary DPS Dynamic Pressure Sensing Technology is utilized to regulate flow rate and monitor pressure during subcutaneous drug delivery [4]

Core Insights - Milestone Scientific Inc. has appointed Jason Papes as Senior Vice President, Global Head of Sales and Marketing, effective immediately, bringing over 30 years of experience in the healthcare and medical technology sectors [1][2] Company Overview - Milestone Scientific Inc. is a technology-focused medical research and development company that specializes in innovative injection technologies and instruments for medical and dental applications [8] Leadership Experience - Jason Papes has extensive experience in sales, marketing, and business development within the healthcare industry, having held leadership roles at large-cap medical technology companies and entrepreneurial ventures [2][3] - His previous roles include executive positions at Stryker Imaging and Brainlab, where he led significant commercial expansions and market share growth [4] Strategic Initiatives - Papes joins Milestone at a critical time as the company rolls out the CompuFlo® Epidural System, having made progress in establishing procedural payment pathways, including Medicare Part B payment rates under CPT® code 0777T [5] - The company is also advancing growth initiatives in its dental segment, focusing on increasing adoption of the STA Single Tooth Anesthesia® System [6] Leadership Commentary - Eric Hines, CEO of Milestone Scientific, emphasized Papes' leadership experience and understanding of the provider and payer landscape as key assets for the company's growth phase [7] - Papes expressed excitement about joining a team committed to innovation and patient safety, aiming to broaden the company's reach and drive value for stakeholders [7]

Core Insights - Milestone Scientific Inc. has appointed Jason Papes as Senior Vice President, Global Head of Sales and Marketing, effective immediately [1] - Mr. Papes has over 30 years of experience in sales, marketing, and business development in the healthcare industry, with a strong background in orthopedics, neurology, pain management, and digital imaging [2] - His previous role was as Founder and Managing Partner of TEN20 Medical Distribution, where he led significant growth and earned multiple Distributor of the Year honors [3] - Mr. Papes has held executive positions at Stryker Imaging and Brainlab, contributing to substantial commercial expansions and market share growth [4] - His appointment comes at a crucial time for Milestone as it rolls out the CompuFlo® Epidural System and establishes payment pathways, including Medicare Part B rates [5] - The company is also focusing on growth in its dental segment, particularly the STA Single Tooth Anesthesia® System, where Mr. Papes will play a key role [6] - CEO Eric Hines emphasized Mr. Papes' leadership experience and market access strategies as vital for the company's growth phase [7] - Mr. Papes holds a Bachelor of Science in Biology and an International MBA, along with executive training in corporate strategy and complex sales [7] Company Overview - Milestone Scientific Inc. is a technology-focused medical research and development company that specializes in innovative injection technologies for medical and dental applications [8] - The company utilizes its proprietary DPS Dynamic Pressure Sensing Technology® to enhance the precision and safety of injections, aiming to improve patient comfort [8]